NewGenIvf Group Limited
NIVF
$0.64
$0.035.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.01M | 1.01M | 1.27M | 1.47M | 1.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.01M | 1.01M | 1.27M | 1.47M | 1.34M |
| Cost of Revenue | 852.90K | 852.90K | 734.50K | 824.00K | 1.02M |
| Gross Profit | 156.90K | 156.90K | 539.10K | 648.80K | 319.50K |
| SG&A Expenses | 1.78M | 1.78M | 1.63M | 432.50K | 463.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.63M | 2.63M | 2.36M | 1.26M | 1.49M |
| Operating Income | -1.62M | -1.62M | -1.09M | 216.30K | -143.80K |
| Income Before Tax | 349.00K | 349.00K | -542.70K | -30.30K | -193.90K |
| Income Tax Expenses | -- | -- | -486.70K | -- | -- |
| Earnings from Continuing Operations | 349.00K | 349.00K | -56.00K | -30.30K | -193.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 13.50K | 13.50K | -52.30K | 10.50K | -4.40K |
| Net Income | 362.50K | 362.50K | -108.20K | -19.90K | -198.30K |
| EBIT | -1.62M | -1.62M | -1.09M | 216.30K | -143.80K |
| EBITDA | -1.62M | -1.62M | -1.09M | 223.00K | -137.50K |
| EPS Basic | 1.31 | 1.31 | -3.73 | -1.96 | -19.54 |
| Normalized Basic EPS | 0.84 | 0.84 | -13.49 | -0.84 | -- |
| EPS Diluted | 0.36 | 0.36 | -3.73 | -1.96 | -19.54 |
| Normalized Diluted EPS | 0.23 | 0.23 | -13.49 | -0.84 | -- |
| Average Basic Shares Outstanding | 275.90K | 275.90K | 29.00K | 10.10K | -- |
| Average Diluted Shares Outstanding | 996.60K | 996.60K | 29.00K | 10.10K | 10.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |